Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Research & Development (2016 - 2025)

Myomo (MYO) has disclosed Research & Development for 10 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 22.32% year-over-year to $1.5 million, compared with a TTM value of $6.9 million through Sep 2025, up 68.17%, and an annual FY2024 reading of $4.8 million, up 81.0% over the prior year.
  • Research & Development was $1.5 million for Q3 2025 at Myomo, down from $2.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.0 million in Q2 2025 and bottomed at $476991.0 in Q1 2023.
  • Average Research & Development over 5 years is $935124.8, with a median of $717256.0 recorded in 2023.
  • The sharpest move saw Research & Development crashed 36.75% in 2022, then skyrocketed 100.47% in 2024.
  • Year by year, Research & Development stood at $790056.0 in 2021, then plummeted by 36.75% to $499674.0 in 2022, then surged by 75.72% to $878006.0 in 2023, then soared by 77.64% to $1.6 million in 2024, then decreased by 2.05% to $1.5 million in 2025.
  • Business Quant data shows Research & Development for MYO at $1.5 million in Q3 2025, $2.0 million in Q2 2025, and $1.8 million in Q1 2025.